GenVec Ditches Liquidation Plan For Novartis Partnership

Flagging biotech firm GenVec Inc. has scrapped plans to dissolve and liquidate assets amid encouraging prospects for a program to develop new hearing loss treatments in partnership with Novartis AG and successful efforts to trim costs, its board said ...read more

  • Tags: